A conference sponsored by the Hereditary Angioedema Association (HAEA) is where I first learned of FIRAZYR® (icatibant injection), a prescription medication approved for the treatment of acute HAE attacks in adults 18 years of age and older.
I was interested in the possibility of David having an on-demand treatment available in a prefilled syringe, but I soon began to have fears:
- How would we get access to this medication?
- What if his doctor wouldn’t prescribe it?
- What if we had questions concerning our medical insurance?
- How would David get trained to self-administer?
We discussed FIRAZYR with David’s HAE treating physician, including risks and benefits, and afterwards, the doctor prescribed FIRAZYR for David.
David and I then faced challenges concerning our medical insurance and getting access to FIRAZYR. Fortunately, we were contacted by a case manager from Shire’s product support service, OnePath®. He helped us with these different challenges of starting David’s new prescription, including verifying our insurance and arranging for a nurse to come to our home to train David on self-administration.
Once that was taken care of, FIRAZYR eventually arrived, and FIRAZYR has been a part of David’s and my life with HAE since we received it.
Now, I no longer feel frustrated when watching television commercials with David that advertise available medications. I simply smile, and think about our lives in this day of modern medicine.
How did you first learn about FIRAZYR? Leave a comment!
If you have HAE, you may want to talk with your doctor about treatment options. If you want to talk about FIRAZYR with your doctor, click here to sign up for more information, including a page that you can download and take with you to your next doctor’s appointment. If you and your doctor decide that FIRAZYR might be the right treatment option for you, he or she can request a single dose of FIRAZYR as a sample for you to try.